Literature DB >> 6107097

Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man.

N Krieg, J F Crul, L H Booij.   

Abstract

The relative potency, time-course of action and cardiovascular effects of Org NC 45, a new non-depolarizing neuromuscular blocking agent, have been compared with those of pancuronium, alcuronium and tubocurarine in 64 anaesthetized patients. The relative potency (ED50) to Org NC 45 was 1.74, 3.69 and 8.57 respectively. In doses which caused useful surgical relaxation, duration of action of Org NC 45 was 34%, 39% and 26% that of pancuronium, alcuroniuym and tubocurarine. After administration of repeated doses no cumulation was seen for Org NC 45. The new drug was free from any effect on arterial pressure and heart rate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107097     DOI: 10.1093/bja/52.8.783

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  13 in total

Review 1.  Clinical pharmacokinetics of neuromuscular blocking drugs.

Authors:  S Agoston; R H Vandenbrom; J M Wierda
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

2.  A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.

Authors:  F Donati; C Meistelman
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

Review 3.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

Review 4.  Org-NC45: a new steroidal non-depolarizing muscle relaxant.

Authors:  L H Booij; T B Vree; J E Crul
Journal:  Pharm Weekbl Sci       Date:  1982-02-19

5.  Nondepolarizing neuromuscular blocking drugs and train-of-four fade.

Authors:  E P McCoy; F M Connolly; R K Mirakhur; P B Loan; L D Paxton
Journal:  Can J Anaesth       Date:  1995-03       Impact factor: 5.063

Review 6.  Neuromuscular blocking drugs.

Authors:  D R Bevan
Journal:  Can Anaesth Soc J       Date:  1983-05

7.  Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.

Authors:  A Williams; H Gyasi; C Melloni; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1982-11

8.  Vecuronium in renal failure.

Authors:  D R Bevan; F Donati; H Gyasi; A Williams
Journal:  Can Anaesth Soc J       Date:  1984-09

Review 9.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 10.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.